Baker Bros. Advisors LP Reata Pharmaceuticals Inc Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
BUY
$102.03 - $184.62 $17.4 Million - $31.5 Million
170,793 Added 321.14%
223,976 $27.7 Million
Q3 2020

Nov 16, 2020
SELL
$93.53 - $163.34 $261,884 - $457,352
-2,800 Reduced 5.0%
53,183 $5.18 Million
Q1 2020

May 15, 2020
BUY
$124.16 - $247.74 $1.86 Million - $3.72 Million
15,000 Added 36.6%
55,983 $8.08 Million
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $3.06 Million - $8.93 Million
40,983 New
40,983 $8.38 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email